PRESS
POSTED 19 May 2020
March 2010
Veryan Closes £3.6m Funding Round to Develop Novel BioMimics 3D Stent Technology and Announces the Commencement of First-in Human Studies Press Release.
©Veryan Medical 2022
BioMimics 3D Vascular Stent System has FDA and CE Mark approval.
BioMimics 3D & Swirling Flow Stent are registered trademarks of Veryan Medical Limited.
Veryan Medical Limited is a member of the Otsuka Medical Devices group of companies.
CAUTION: Federal law restricts this device to sale by or on the order of a physician.
PAM 14 Version 3.0
